NoticeThis is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
Sarcopenia is characterized by loss of the muscle mass and function. It develops with age and is associated with a high risk of functional loss in complex activities of daily living, deterioration and quality of life, falls and injuries, patient institutionalization, hospitalization, and mortality in older adults.
1 total trials1 recruiting
Filter these 1 trials by phase, country, sponsor and more.